Jesy Nelson Told Her Twin Babies May ‘Never Walk’

Jesy Nelson Opens Up About Her Twins’ Rare Diagnosis

Jesy Nelson, the former Little Mix singer, recently revealed a deeply personal and emotional update about her twin daughters, Ocean Jade and Story Monroe Nelson-Foster. Born prematurely in May 2025, the twins have been diagnosed with Spinal Muscular Atrophy (SMA) type 1, a rare and severe genetic disorder that affects muscle strength and movement. Jesy shared this news in a heartfelt Instagram video, explaining the challenges her family has faced since the diagnosis and the uncertain road ahead.

SMA is a progressive muscle-wasting disease that impacts every muscle in the body, including those responsible for breathing, swallowing, and movement. Jesy described it as the “most severe muscular disease,” emphasizing how it affects her daughters’ ability to move their legs and feed properly. The diagnosis has been devastating, with doctors informing Jesy that her twins may “probably never walk” and could face significant disabilities, including the inability to regain neck strength.

Understanding Spinal Muscular Atrophy and Its Impact

Spinal Muscular Atrophy is a genetic condition caused by a mutation in the SMN1 gene, which is responsible for producing a protein essential for the survival of motor neurons. Without this protein, motor neurons deteriorate, leading to muscle weakness and atrophy. SMA type 1, the most severe form, typically manifests in infancy and can be life-threatening if left untreated.

Jesy Nelson’s twins were assessed at Great Ormond Street Hospital in London, where the diagnosis was confirmed. The hospital is renowned for its expertise in treating complex pediatric conditions, including SMA. The prognosis for SMA type 1 is often grim, with many children not surviving past the age of two without intervention. However, recent advances in gene therapy have brought new hope to families affected by this disease.

Gene Therapy and Treatment Options

One of the most promising treatments for SMA is a gene therapy drug called Zolgensma, approved by the NHS in 2021. This groundbreaking therapy delivers a healthy copy of the SMN1 gene to the patient’s cells, potentially halting the progression of the disease. Timing is critical, as irreversible nerve damage can occur if treatment is delayed.

Jesy Nelson has expressed her gratitude for the treatment her daughters have received, acknowledging that without it, their lives could be at serious risk. Since the diagnosis, Jesy has taken on the role of caregiver, managing breathing machines and other medical equipment to support her twins’ health.

Despite the challenges, Jesy remains hopeful and determined. She believes her daughters will “defy all the odds” with the right support and care. Her openness about the diagnosis aims to raise awareness about SMA and encourage early screening, which can be life-saving.

The Importance of Early Diagnosis and Awareness

Currently, SMA screening in the UK is limited to newborns with a family history of the condition. However, organizations like SMA UK advocate for the inclusion of SMA in the routine newborn blood spot test, which already screens for several rare but serious conditions. Early diagnosis is crucial because treatments like gene therapy are most effective before significant muscle damage occurs.

Jesy’s decision to share her family’s story publicly highlights the need for greater awareness and faster diagnosis. According to SMA UK, approximately 47 babies are born with SMA in the UK each year, and about one in 40 people carry the gene mutation that causes the disease. Increasing public knowledge can lead to earlier intervention and better outcomes for affected children.

Jesy Nelson’s Journey as a Mother and Advocate

Jesy Nelson’s journey into motherhood has been marked by both joy and hardship. She gave birth to her twins prematurely at 31 weeks, after experiencing rare pregnancy complications. In October 2025, Jesy posted on Instagram expressing pride in her body and the miracle of motherhood, despite the challenges she faced.

Since leaving Little Mix in 2020, Jesy has pursued a solo music career but has also embraced her role as a mother and advocate for children with SMA. Her transparency about her daughters’ condition has resonated with many, inspiring support and empathy from fans and the wider community.

Jesy’s partner, musician Zion Foster, also shared a touching message alongside a smiling photo of the twins, showing their resilience and the family’s unwavering love.

Conclusion

Jesy Nelson’s courageous disclosure about her twin daughters’ diagnosis with Spinal Muscular Atrophy shines a light on a rare but devastating condition. Her story underscores the critical importance of early diagnosis and access to life-changing treatments like gene therapy. While the prognosis is challenging, Jesy’s hope and determination offer inspiration to families facing similar battles.

If you want to learn more about SMA or support research and awareness efforts, consider visiting SMA UK or speaking to your healthcare provider about newborn screening options. Early detection can make all the difference.

Stay informed, spread awareness, and join Jesy Nelson in advocating for children affected by SMA. Together, we can help ensure that more families receive timely diagnoses and access to vital treatments.